[1] |
Prieto⁃Torres L, Rodriguez⁃Pinilla SM, Onaindia A, et al. CD30⁃positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies[J]. Haematologica, 2019,104(2):226⁃235. doi: 10.3324/haematol.2018.197152.
|
[2] |
Taylor J, Xiao W, Abdel⁃Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics[J]. Blood, 2017,130(4):410⁃423. doi: 10.1182/blood⁃2017⁃02⁃734541.
|
[3] |
Alonso A, Merlo JJ, Na S, et al. Inhibition of T cell antigen receptor signaling by VHR⁃related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR)[J]. J Biol Chem, 2002,277(7):5524⁃5528. doi: 10.1074/jbc.M107653200.
|
[4] |
Falini B, Fizzotti M, Pucciarini A, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells[J]. Blood, 2000,95(6):2084⁃2092.
|
[5] |
Onaindia A, Montes⁃Moreno S, Rodríguez⁃Pinilla SM, et al. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features[J]. Histopathology, 2015,66(6):846⁃855. doi: 10.1111/his.12529.
|
[6] |
Nieto⁃Benito LM, Parra⁃Blanco V, Gómez⁃Navarro Y, et al. Histopathological features and outcomes of DUSP22 rearrangement in primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature[J]. J Eur Acad Dermatol Venereol, 2021,35(10):e670⁃e672. doi: 10.1111/jdv.17375.
|
[7] |
Karai LJ, Kadin ME, Hsi ED, et al. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis[J]. Am J Surg Pathol, 2013,37(8):1173⁃1181. doi: 10.1097/PAS. 0b013e318282d01e.
|
[8] |
Olson LC, Cheng E, Mathew S, et al. Primary cutaneous anaplastic large⁃cell lymphoma with 6p25.3 rearrangement in a cardiac transplant recipient: a case report and review of the literature[J]. Am J Dermatopathol, 2016,38(6):461⁃465. doi: 10.1097/DAD.0000000000000505.
|
[9] |
Xue YN, Wang Z, Sun JF, et al. Primary cutaneous anaplastic large⁃cell lymphoma with 6p25.3 rearrangement exhibits a biphasic histopathologic pattern: two case reports and literature review[J]. J Cutan Pathol, 2021,48(12):1463⁃1470. doi: 10. 1111/cup.14089.
|
[10] |
Dutra E, Maia T, Cabeçadas J. Primary cutaneous anaplastic large cell lymphoma with 6p25.3 rearrangement and epidermotropism[J]. Am J Dermatopathol, 2022,44(3):196⁃197. doi: 10.1097/DAD.0000000000002084.
|
[11] |
Kluk J, Child F, Robson A. Lymphomatoid papulosis with 6p25.3 rearrangement: a further case of the newly described variant[J]. Br J Dermatol, 2014,171(6):1590⁃1592. doi: 10.1111/bjd.13092.
|
[12] |
Dummer R, Vermeer MH, Scarisbrick JJ, et al. Cutaneous T cell lymphoma[J]. Nat Rev Dis Primers, 2021,7(1):61. doi: 10.1038/s41572⁃021⁃00296⁃9.
|
[13] |
Daragon C, Beltzung F, Vergier B, et al. Biphasic pathological pattern in transformed mycosis fungoides not associated with DUSP22⁃IRF4 translocation[J]. Histopathology, 2019,74(4):668⁃671. doi: 10.1111/his.13794.
|
[14] |
Pham⁃Ledard A, Prochazkova⁃Carlotti M, Laharanne E, et al. IRF4 gene rearrangements define a subgroup of CD30⁃positive cutaneous T⁃cell lymphoma: a study of 54 cases[J]. J Invest Dermatol, 2010,130(3):816⁃825. doi: 10.1038/jid.2009.314.
|
[15] |
Martinez⁃Cabriales SA, Walsh S, Sade S, et al. Lymphomatoid papulosis: an update and review[J]. J Eur Acad Dermatol Venereol, 2020,34(1):59⁃73. doi: 10.1111/jdv.15931.
|
[16] |
Stoll JR, Willner J, Oh Y, et al. Primary cutaneous T⁃cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis. J Am Acad Dermatol. 2021 Nov;85(5):1073⁃1090.
|
[17] |
Feldman AL, Grogg KL, Knudson RA, et al. Secondary cutaneous involvement by systemic anaplastic lymphoma kinase⁃negative anaplastic large⁃cell lymphoma with 6p25.3 rearrangement[J]. Histopathology, 2015,67(6):932⁃935. doi: 10.1111/his.12729.
|
[18] |
Diaz de la Pinta FJ, Machan S, Manso Alonso R, et al. DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large⁃cell lymphoma and lymphomatoid papulosis[J]. Histopathology, 2022,80(2):446⁃449. doi: 10.1111/his.14448.
|
[19] |
Savage KJ, Slack GW. DUSP22⁃rearranged ALK⁃negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome[J]. Haematologica, 2023,108(6):1463⁃1467. doi: 10.3324/haematol.2022.282025.
|